From chaos to symbiosis: exploring adaptive co-evolution strategies for generative AI and research integrity systems.

IF 3.1 1区 哲学 Q1 ETHICS
Wenqing Miao, Huan Zang, Qirui Liu, Tianlei Zheng, Yan Zhou, Chunmei Liu, Na Yang, Hengzhi Zhang, Yuwan Zhang, Ying Zhang, Shengli Li, Shenyang Zhang, Hao Zhang
{"title":"From chaos to symbiosis: exploring adaptive co-evolution strategies for generative AI and research integrity systems.","authors":"Wenqing Miao, Huan Zang, Qirui Liu, Tianlei Zheng, Yan Zhou, Chunmei Liu, Na Yang, Hengzhi Zhang, Yuwan Zhang, Ying Zhang, Shengli Li, Shenyang Zhang, Hao Zhang","doi":"10.1186/s12910-025-01288-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The information age has transformed technologies across disciplines. Generative artificial intelligence (GenAI), as an emerging technology, has integrated into scientific research. Recent studies identify GenAI-related scientific research integrity concerns. Using Complex Adaptive Systems (CAS) theory, this research examines risk factors and preventive measures for each agent within the scientific research integrity management system during GenAI adoption, providing new perspectives for integrity management.</p><p><strong>Method: </strong>This study applies CAS theory to analyze the scientific research integrity management system, identifying four core micro-level agents: researchers, research subjects, scientific research administrators, and academic publishing institutions. It examines macro-system complexity, agent adaptability, and the impact of agent interactions on the overall system. This framework enables analysis of GenAI's effects on the research integrity management system.</p><p><strong>Results: </strong>The scientific research integrity management system exhibits structural, hierarchical, and multidimensional complexities, with internal circulation of policy, funding, and information elements. In response to GenAI integration, four micro-level agents-researchers, research subjects, scientific research administrators, and academic publishing institutions-adapt their behaviors to systemic changes. Through these interactions, behavioral outcomes emerge at the macro level, driving evolution of the research integrity management system.</p><p><strong>Conclusions: </strong>Risks of scientific misconduct permeate the entire research process and require urgent governance. This study recommends that scientific research administrators promptly define applicable boundaries for GenAI in research to guide researchers. Concurrently, they should collaborate with relevant departments to establish regulatory frameworks addressing potential GenAI-related misconduct. Academic publishing institutions must assume quality assurance responsibilities by strengthening review and disclosure protocols. Furthermore, research integrity considerations should be systematically integrated into GenAI's technological development and refinement.</p><p><strong>Highlights: </strong>● Develops an analytical framework grounded in Complex Adaptive Systems (CAS) theory to map evolving interactions among researchers, research subjects, scientific research administrators, and academic publishing institutions within GenAI-integrated research ecosystems.  ● Identifies self-reinforcing dynamics between GenAI adoption and integrity governance, wherein adaptive rule adjustments by agents reshape system-wide integrity thresholds.  ● Proposes adaptive governance mechanisms that balance innovation safeguards with integrity guardrails, emphasizing context-sensitive policy calibration over universal solutions.</p>","PeriodicalId":55348,"journal":{"name":"BMC Medical Ethics","volume":"26 1","pages":"120"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12465495/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medical Ethics","FirstCategoryId":"98","ListUrlMain":"https://doi.org/10.1186/s12910-025-01288-0","RegionNum":1,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ETHICS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The information age has transformed technologies across disciplines. Generative artificial intelligence (GenAI), as an emerging technology, has integrated into scientific research. Recent studies identify GenAI-related scientific research integrity concerns. Using Complex Adaptive Systems (CAS) theory, this research examines risk factors and preventive measures for each agent within the scientific research integrity management system during GenAI adoption, providing new perspectives for integrity management.

Method: This study applies CAS theory to analyze the scientific research integrity management system, identifying four core micro-level agents: researchers, research subjects, scientific research administrators, and academic publishing institutions. It examines macro-system complexity, agent adaptability, and the impact of agent interactions on the overall system. This framework enables analysis of GenAI's effects on the research integrity management system.

Results: The scientific research integrity management system exhibits structural, hierarchical, and multidimensional complexities, with internal circulation of policy, funding, and information elements. In response to GenAI integration, four micro-level agents-researchers, research subjects, scientific research administrators, and academic publishing institutions-adapt their behaviors to systemic changes. Through these interactions, behavioral outcomes emerge at the macro level, driving evolution of the research integrity management system.

Conclusions: Risks of scientific misconduct permeate the entire research process and require urgent governance. This study recommends that scientific research administrators promptly define applicable boundaries for GenAI in research to guide researchers. Concurrently, they should collaborate with relevant departments to establish regulatory frameworks addressing potential GenAI-related misconduct. Academic publishing institutions must assume quality assurance responsibilities by strengthening review and disclosure protocols. Furthermore, research integrity considerations should be systematically integrated into GenAI's technological development and refinement.

Highlights: ● Develops an analytical framework grounded in Complex Adaptive Systems (CAS) theory to map evolving interactions among researchers, research subjects, scientific research administrators, and academic publishing institutions within GenAI-integrated research ecosystems.  ● Identifies self-reinforcing dynamics between GenAI adoption and integrity governance, wherein adaptive rule adjustments by agents reshape system-wide integrity thresholds.  ● Proposes adaptive governance mechanisms that balance innovation safeguards with integrity guardrails, emphasizing context-sensitive policy calibration over universal solutions.

Abstract Image

Abstract Image

Abstract Image

从混沌到共生:探索生成式人工智能和研究完整性系统的自适应协同进化策略。
目的:信息时代已经改变了跨学科的技术。生成式人工智能(GenAI)作为一门新兴技术,已经融入到科学研究中。最近的研究发现了与基因相关的科研诚信问题。本研究运用复杂适应系统(CAS)理论,探讨了GenAI采用过程中科研诚信管理系统中各主体的风险因素及防范措施,为诚信管理提供了新的视角。方法:运用CAS理论对科研诚信管理体系进行分析,确定科研人员、科研主体、科研管理者和学术出版机构四个核心微观层面主体。它考察了宏观系统的复杂性、智能体的适应性以及智能体相互作用对整个系统的影响。这个框架能够分析GenAI对科研诚信管理系统的影响。结果:科研诚信管理体系表现出结构性、层次性和多维性的复杂性,政策要素、资金要素和信息要素之间存在内在循环。作为对GenAI整合的回应,研究者、研究对象、科研管理者和学术出版机构这四个微观层面的主体调整了他们的行为以适应系统变化。通过这些相互作用,行为结果在宏观层面上显现出来,推动了科研诚信管理系统的演变。结论:科学不端行为的风险贯穿于整个研究过程,迫切需要治理。本研究建议科研管理者及时界定GenAI在科研中的适用边界,以指导科研人员。同时,他们应该与相关部门合作,建立监管框架,解决潜在的基因相关不当行为。学术出版机构必须承担质量保证责任,加强审查和披露协议。此外,应将研究诚信考虑系统地纳入GenAI的技术开发和改进中。●开发一个基于复杂适应系统(CAS)理论的分析框架,以映射在genai集成研究生态系统中研究人员、研究对象、科研管理者和学术出版机构之间不断发展的相互作用。●识别GenAI采用和完整性治理之间的自我强化动态,其中代理的自适应规则调整重塑了系统范围的完整性阈值。●提出适应性治理机制,平衡创新保障和诚信护栏,强调对环境敏感的政策校准,而不是通用解决方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Medical Ethics
BMC Medical Ethics MEDICAL ETHICS-
CiteScore
5.20
自引率
7.40%
发文量
108
审稿时长
>12 weeks
期刊介绍: BMC Medical Ethics is an open access journal publishing original peer-reviewed research articles in relation to the ethical aspects of biomedical research and clinical practice, including professional choices and conduct, medical technologies, healthcare systems and health policies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信